 | Up a level |
Journal Article
Goltz, D., Gevensleben, H., Bootz, F., Kristiansen, G., Dietrich, D. and Landsberg, J. (2017). Prognostic significance of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PDL2) promoter methylation for melanoma patients. Exp. Dermatol., 26 (3). S. E83 - 1. HOBOKEN: WILEY. ISSN 1600-0625
Goltz, D., Gevensleben, H., Kristiansen, G., Vogt, T., Hoffmann, F., Dietrich, D. and Landsberg, J. (2017). Prognostic significance and predictive value to anti-PD1 treatment of promoter methylation of PDCD1 (PD-1), CD274 (PD-L1) and PDCD1LG2 (PD-L2) for melanoma patients. J. Dtsch. Dermatol. Ges., 15. S. 2 - 3. HOBOKEN: WILEY. ISSN 1610-0387